138 related articles for article (PubMed ID: 6186756)
1. Synthesis and secretion of the fibrinolytic components, including alpha 2-antiplasmin, by a human hepatoma cell line.
Fair DS; Plow EF
J Lab Clin Med; 1983 Mar; 101(3):372-84. PubMed ID: 6186756
[TBL] [Abstract][Full Text] [Related]
2. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2.
Alessi MC; Juhan-Vague I; Kooistra T; Declerck PJ; Collen D
Thromb Haemost; 1988 Dec; 60(3):491-4. PubMed ID: 3149048
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of the inhibition of plasmin in acidified human plasma.
Lijnen HR; Maes M; Castel M; Samama M; Collen D
Thromb Haemost; 1982 Dec; 48(3):257-9. PubMed ID: 6219470
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
6. Human hepatoma cell line plasminogen activator.
Levin EG; Fair DS; Loskutoff DJ
J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2.
Sprengers ED; Princen HM; Kooistra T; van Hinsbergh VW
J Lab Clin Med; 1985 Jun; 105(6):751-8. PubMed ID: 2987382
[TBL] [Abstract][Full Text] [Related]
8. Modified crossed immunoelectrophoresis to study with whole plasma the reversible complex formation of histidine-rich glycoprotein with plasminogen.
Kluft C; Los P
Thromb Haemost; 1988 Dec; 60(3):411-4. PubMed ID: 2467400
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin synthesized by a human hepatoma cell line.
Glasgow JE; Colman RW
Cancer Res; 1984 Jul; 44(7):3022-8. PubMed ID: 6327032
[TBL] [Abstract][Full Text] [Related]
10. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
[TBL] [Abstract][Full Text] [Related]
11. The influence of L-asparaginase therapy on the fibrinolytic system.
Vellenga E; Kluft C; Mulder NH; Wijngaards G; Nieweg HO
Br J Haematol; 1984 Jun; 57(2):247-54. PubMed ID: 6203549
[TBL] [Abstract][Full Text] [Related]
12. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.
Silence K; Collen D; Lijnen HR
J Biol Chem; 1993 May; 268(13):9811-6. PubMed ID: 7683664
[TBL] [Abstract][Full Text] [Related]
13. [Levels of plasminogen and alpha 2-antiplasmin in blood of patients with prostatic tumor].
Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
Pol Tyg Lek; 1996 Feb; 51(6-9):86-8. PubMed ID: 8756739
[TBL] [Abstract][Full Text] [Related]
14. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
15. The kinetics of plasmin inhibition by aprotinin in vivo.
Kang HM; Kalnoski MH; Frederick M; Chandler WL
Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
[TBL] [Abstract][Full Text] [Related]
16. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.
Nakabayashi H; Taketa K; Miyano K; Yamane T; Sato J
Cancer Res; 1982 Sep; 42(9):3858-63. PubMed ID: 6286115
[TBL] [Abstract][Full Text] [Related]
17. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
[TBL] [Abstract][Full Text] [Related]
18. Binding and activation of plasminogen at the surface of human keratinocytes.
Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines.
Saito H; Goodnough LT; Knowles BB; Aden DP
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5684-7. PubMed ID: 6291058
[TBL] [Abstract][Full Text] [Related]
20. Different NH2-terminal form with 12 additional residues of alpha 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells.
Koyama T; Koike Y; Toyota S; Miyagi F; Suzuki N; Aoki N
Biochem Biophys Res Commun; 1994 Apr; 200(1):417-22. PubMed ID: 8166714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
